This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Medytox Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Young Rae Lee: Innovator in Recombinant Polynucleotide Technology
Introduction
Young Rae Lee is a prominent inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polynucleotides. His innovative work has led to advancements that can measure protease levels effectively.
Latest Patents
Young Rae Lee holds a patent for a recombinant polynucleotide coding for a polypeptide that comprises a reporter moiety, a substrate moiety, and a destabilizing moiety. This invention includes a host cell that incorporates the recombinant polynucleotide, which is utilized to measure the level of a protease. The patent represents a significant step forward in biotechnological applications.
Career Highlights
Currently, Young Rae Lee is associated with Medytox Inc., a company known for its focus on biopharmaceuticals. His work at Medytox Inc. has allowed him to further his research and development efforts in the field of biotechnology.
Collaborations
Young Rae Lee collaborates with notable colleagues, including Hyun Ho Jung and Gi Hyeok Yang. Their combined expertise contributes to the innovative environment at Medytox Inc.
Conclusion
Young Rae Lee's contributions to recombinant polynucleotide technology highlight his role as a key innovator in biotechnology. His patent and ongoing work at Medytox Inc. demonstrate his commitment to advancing scientific knowledge and applications in this vital field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile